RxDoctor Payments Data

Vanessa Green, DO

Family Medicine · Manchester, TNNPI 1023204278

Payments from drug & device makers

$416in general payments, 2019–2025

Across 20 payments — averaging $20.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Revance Therapeutics, Inc.$127
  • AbbVie$112
  • Merz North America, Inc.$41
  • Novo Nordisk$34
  • Lilly USA, LLC$29
  • Exact Sciences$21
  • plus $52 from 3 others

What the payments were for

  • Food & beverage$416100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$416 in reported general payments places this provider in the 45th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$29,129
Medicare patients
66
Services billed
553

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide33$32,331
MounjaroTirzepatide26$26,352
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$14,893
JardianceEmpagliflozin13$12,043
Fluticasone-SalmeterolFluticasone Propion/Salmeterol15$2,804
Wixela InhubFluticasone Propion/Salmeterol14$1,298
Estradiol23$1,068
Pantoprazole Sodium47$914
Albuterol Sulfate HfaAlbuterol Sulfate28$868
Atorvastatin Calcium72$801
Duloxetine Hcl36$679
Levothyroxine Sodium95$666
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide16$665
Lisinopril65$489
Bupropion XlBupropion Hcl13$461

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$34$32,33133 claims
Lilly USA, LLCMounjaro$29$26,35226 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Manchester

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →